HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 832 | 1002 | 83.0% | |
| HF 4 | 2012 | 869 | 1042 | 83.4% | |
| HF 4 | 2013 | 916 | 1071 | 85.5% | |
| HF004 | 2014 | 410 | 448 | 91.5% | |
| HF004 | 2015 | 443 | 480 | 92.3% | |
| HF004 | 2016 | 538 | 584 | 92.1% | |
| HF004 | 2017 | 570 | 622 | 91.6% | |
| HF004 | 2018 | 658 | 708 | 92.9% | |
| HF004 | 2019 | 734 | 793 | 92.6% | |
| HF004 | 2020 | 855 | 943 | 90.7% | |
| HF006 | 2021 | 1077 | 1183 | 91.0% | |
| HF006 | 2022 | 1279 | 1352 | 94.6% | |
| HF006 | 2023 | 1473 | 1531 | 96.2% |
